Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine for prevention of emergence agitation after nasal endoscopic surgery
ChiCTR2500112380Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Southern Medical University
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Emergence agitation (EA) (4 arms), sponsored by The Third Affiliated Hospital of Southern Medical University. Primary endpoint: Sedation-Agitation Scale (Riker SAS). Planned start Nov 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2500112380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112380.